IIFL Home Finance, a subsidiary of IIFL Finance, is set to raise up to Rs 500 crore through the issuance of secured non-convertible debentures (NCDs). This move aims to strengthen the company’s financial position and fund future growth initiatives. Learn more about the NCD offering, its potential benefits for investors, and the company’s recent financial performance.
State Bank of India has successfully raised Rs 50,000 crore in FY25 through a strategic mix of infrastructure, AT1, Tier 2, and long-term bonds. This significant fundraising effort enhances SBI's capital base, enabling the bank to support critical infrastructure projects and expand its lending capacity, while positioning it for sustainable growth in the coming years.
Shree Renuka Sugar Ltd. has fully exited its Mauritius-based subsidiary, Shree Renuka Global Ventures Ltd., by selling its remaining 17.1% stake to Freeway Trading Ltd. This strategic move follows an earlier divestment in 2019 and aligns with the company's focus on strengthening its core operations in India, including sugar production and ethanol manufacturing.
Pavna Industries has reported a stunning 76% increase in net profit for Q2 FY25, fueled by strategic initiatives and a commitment to the burgeoning electric vehicle market. This blog delves into the company’s financial highlights, management insights, and future growth prospects, positioning Pavna as a key player in the automotive sector.
Zydus Wellness has announced the acquisition of Naturell (India) for Rs 390 crore, a strategic move to enhance its portfolio in the growing healthy snacking segment. This deal promises to expand Zydus' market presence and leverage Naturell's established brands, aligning perfectly with consumer trends towards health and wellness. Discover the implications and benefits of this significant acquisition.
Torrent Pharmaceuticals recently saw its promoter offload a 2.92% stake, raising over Rs 3,000 crore. Despite this significant transaction, the company reported strong Q2 results, with a 17% rise in net profit. Dive into our analysis of market reactions, analyst ratings, and what this means for the future of Torrent Pharma.
Sharda Cropchem's stock surged 18% following impressive Q2 FY25 results, showcasing a strong recovery with a profit of ₹42.40 crore. Explore the key financial highlights, growth strategies, and future outlook that position the company for continued success in the agrochemicals sector.
NMDC Group has reported outstanding financial results for the first nine months of 2024, achieving a net profit of AED 2.2 billion—a 45% increase from last year. With revenues soaring by 68% to AED 18.5 billion, the company credits its success to a strong project pipeline and strategic expansions. Discover the key insights from leadership and the Group’s future plans for sustained growth.
Indus Towers has delivered impressive Q2 results, showcasing a 71.7% increase in net profit, reaching ₹2,224 crore—well above analyst estimates. Despite a slight dip in stock price post-announcement, the company’s revenue growth and expanded EBITDA margin highlight its operational strength. Explore the key financial highlights and insights into future growth as Indus Towers navigates the evolving telecom landscape.